Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer

Name: Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer
License: Public Domain

Coherus Oncology, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

prostate-cancer

metastatic castration-resistant prostate cancer, prostate cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152427
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.